Enteric coated pharmaceutical composition and use thereof
A pharmaceutical composition, enteric-coated technology, applied in the field of phosphate binders, can solve unsatisfactory problems
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0022] The term "chitin citrate" refers to a conjugate comprising a chitin moiety and a citric acid moiety. The chitin moiety and the citric acid moiety are preferably conjugated together through the hydroxyl groups of the chitin moiety. In a more preferred embodiment, the chitin moiety has 50 to 75% deacetylation. In another more preferred embodiment, the chitin moiety has 55 to 70% deacetylation. In yet another more preferred embodiment, the deacetylation of the chitin moiety is 55%, 56%, 57%, 58%, 59%, 60%, 61%, 62%, 63%, 64%, 65% %, 66%, 67%, 68%, 69%, or 70%. In an alternative embodiment, the weight average molecular weight of the chitin fraction is 15,000 to 40,000 Daltons; preferably, the weight average molecular weight is 20,000 to 35,000 Daltons.
[0023] It is generally believed that the higher the degree of deacetylation of the chitin moiety, the more active functional groups available for binding phosphate, thus providing better phosphate binding ability. There...
PUM
| Property | Measurement | Unit |
|---|---|---|
| molecular weight | aaaaa | aaaaa |
| molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


